Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth's Q4 Revenues Climb 48 Percent

NEW YORK (GenomeWeb News) – MDxHealth today reported that its fourth-quarter 2011 revenues increased 48 percent year over year, driven by its pharmaco diagnostic business.

The Liege, Belgium-based firm reported Q4 revenues of €900,000 versus €600,000.

"The growth in revenues from our pharmaco diagnostic business in Q4 2011 of nearly 50 percent versus Q4 2010 represents continued validation and acceptance of our epigenetic technology and tests within the pharmaceutical industry," said MDxHealth CEO Jan Groen said in a statement. "Additionally, we made important strides in the development and validation of our ConfirmMDx for Prostate Cancer test and significantly advanced preparations for product launch in the coming months."

MDxHealth didn't provide its net earnings/loss for the quarter.

The firm reported full-year 2011 revenues of €2.7 million, up 8 percent from €2.5 million. Its full-year net loss declined to €6.9 million, or €.37 per share, from €8.3 million, or €.63 per share.

It trimmed its operating expenses for the year to €9.5 million from €10.5 million. The decline was due to a restructuring effort begun in 2010.

The molecular and companion diagnostics company finished the year with €11.1 million in cash and cash equivalents.

Two months ago, MDxHealth received CLIA certification for its lab in Irvine, Calif. Today, it said that it is currently building the sales and marketing infrastructure to support the launch of its ConfirmMDx for Prostate Cancer test in the US during the first half of this year.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.